Pieter Mestdagh
ORCID: 0000-0001-7821-9684
· 4 papers in corpus
meta-analysis
2024
Any ASRM stage [19] of en-dometriosis, any menstrual stage and any technique for miRNA expression analysis were allowed. Participant or population Patients with endometriosis.Intervention Assesment of circulating biomarkers.Comparator Asymp…
review
2024
The aim of this systematic review is to assess the power of circulating miRNAs as biomarkers as a diagnostic tool in endometriosis. In endometriosis-suspected women with uncertain imaging, the only way to confirm or exclude endometriosis wi…
other
2022
BACKGROUND: Most ovarian cancer patients are diagnosed at an advanced stage and have a high mortality rate. Current screening strategies fail to improve prognosis because markers that are sensitive for early stage disease are lacking. This …
diagnostic-accuracy
2019
STUDY QUESTION: Can plasma miRNAs be used for the non-invasive diagnosis of endometriosis in infertile women? SUMMARY ANSWER: miRNA-based diagnostic models for endometriosis failed the test of independent validation. WHAT IS KNOWN ALREADY…